iF647 Anti-Human HLA-DR/DP/DQ Antibody
英诺赛图(InnoCyto)的 iF647 Anti-Human HLA-DR/DP/DQ Antibody(克隆 IVA12) 为鼠源 IgG1 单克隆抗体,靶向 Human,iF647 标记(633 nm 红色激光激发),适用于流式细胞术。提供 25 tests、100 tests 规格,目录价 ¥1,559 起,仅供科研使用(RUO)。
01产品图片

02产品简介
英诺赛图(InnoCyto)的 iF647 Anti-Human HLA-DR/DP/DQ Antibody(克隆 IVA12) 为鼠源 IgG1 单克隆抗体,靶向 Human,iF647 标记(633 nm 红色激光激发),适用于流式细胞术。提供 25 tests、100 tests 规格,目录价 ¥1,559 起,仅供科研使用(RUO)。
03产品介绍
规格与货号
118903 | 25 tests | ¥1,559
118904 | 100 tests | ¥4,271
Product Details
Target Name|HLA-DR, HLA-DP, and HLA-DQ, MHC class II, pan HLA-II, pan MHC-II
Regulatory Status|RUO
Protein Concentration|Supplied at a lot-specific concentration.
Storage & Handling|The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Recommended Usage|For flow cytometric staining, it is recommended to use 5 µL of this reagent per 0.5-1.0 million cells in a 100 µL volume. Optimal reagent performance should be determined by titration for each specific application. iF647 has an excitation max at 656 nm and an emission max at 670 nm.
See All Formats|Clone IVA12
Background Information
Human HLA-DR, HLA-DP, and HLA-DQ are the three major classical human leukocyte antigen (HLA) class II molecules encoded within the major histocompatibility complex (MHC) on chromosome 6. These cell-surface glycoproteins are primarily expressed on professional antigen-presenting cells, including dendritic cells, macrophages, and B lymphocytes. Their principal function is to present peptides derived from extracellular proteins to CD4+ T helper cells, initiating and regulating adaptive immune responses. This process is essential for host defense against pathogens and for the development of immune memory.
Each HLA class II molecule consists of a polymorphic α (alpha) chain and β (beta) chain that together form a peptide-binding groove capable of accommodating peptides approximately 13–25 amino acids in length. The groove binds peptides generated in endosomal and lysosomal compartments following antigen processing. Peptide loading is facilitated by accessory molecules such as HLA-DM after removal of the invariant chain-derived CLIP peptide. The extensive genetic polymorphism of HLA-DR, HLA-DP, and HLA-DQ enables presentation of a broad repertoire of peptide ligands, including self and foreign antigens.
Specific HLA class II alleles are strongly associated with autoimmune diseases. For example, HLA-DR and HLA-DQ variants contribute to susceptibility to type 1 diabetes, rheumatoid arthritis, celiac disease, multiple sclerosis, and systemic lupus erythematosus. Certain HLA-DP alleles have also been linked to chronic hepatitis B outcomes and other immune-mediated disorders. These molecules are important in transplantation because mismatched HLA alleles increase the risk of graft rejection.
Therapeutically, HLA-DR, HLA-DP, and HLA-DQ are used in tissue matching for organ and stem cell transplantation, disease risk assessment, vaccine development, and immunotherapy. Their ability to present antigenic peptides also makes them attractive targets for antigen-specific tolerance strategies and personalized immunotherapies designed to modulate pathogenic T-cell responses while preserving protective immunity.
Data Sheets
Human peripheral blood lymphocytes were stained with PB Anti-Human CD19 clone SJ25C1 and i F647 Anti-Human HLA-DR/DP/DQ clone IVA12 (left) or an isotype control (right).
04完整参数表
参数由厂商资料整理,采购前请以最终报价单与技术协议为准。
05荣誉与资质
该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。
- 营业执照未上传
- 品牌授权未上传
- 产品检测报告未上传
- 会员身份
- 收费会员
- 经营身份
- 原厂
- 成立年份
- 2020 年
- 所在地
- 上海
- 收录条目
- 1865 个
- 平台核验
- 平台代管
06品牌与供应商
InnoCyto(上海英诺赛图生物科技有限公司)致力于通过开发高质量细胞分析试剂,加速科学发现进程。公司为研究人员提供细胞层面探索所需的工具,推动免疫学、肿瘤学等多领域的研究创新。 核心团队拥有丰富的行业经验,曾参与全球头部生命科学公司的标杆项目搭建,深刻理解工业界与学术研究的前沿需求。试剂从设计之初即以精确性、一致性、高性能为核心标准,让科学家能把精力集中在最核心的研究工作上。 公司将深厚的科学积累与对品质的严格承诺相结合,力争成为全球研究人员信赖的合作伙伴。产品线覆盖经验证的一抗与二抗、同型对照、生物类似药抗体、重组蛋白、细胞因子、免疫检测试剂盒及配套试剂,并提供重组蛋白/抗体表达与标记偶联服务。
品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。
07同类条目
同一子类内的条目才具备可比性。跨子类比较参数通常没有意义。
08同品牌其他条目
上海英诺赛图 在本目录共 1865 个条目,除本条外还有:
科研在线(TeleVM). iF647 Anti-Human HLA-DR/DP/DQ Antibody(118903)[EB/OL]. 产品目录, 2026-11-12. https://www.suprotek.cn/products/item/if647-anti-human-hla-dr-dp-dq-antibody.html.
TeleVM. (2026, November 12). iF647 Anti-Human HLA-DR/DP/DQ Antibody(118903). 产品目录. https://www.suprotek.cn/products/item/if647-anti-human-hla-dr-dp-dq-antibody.html
@misc{biocsp_item_if647_anti_human_hla_dr_dp_dq_antibody,
title = {iF647 Anti-Human HLA-DR/DP/DQ Antibody(118903)},
author = {{科研在线}},
year = {2026},
howpublished = {产品目录},
note = {更新于 2026-11-12,产品目录},
url = {https://www.suprotek.cn/products/item/if647-anti-human-hla-dr-dp-dq-antibody.html}
}
GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。
许可:CC BY-NC 4.0 · 转载注明来源